Zooplankton biomass estimation from digitized images: a comparison between subtropical and Antarctic organisms

The measurement of mesozooplankton biomass in the ocean requires the use of analytical procedures that destroy the samples. Alternatively, the development of methods to estimate biomass from optical systems and appropriate conversion factors could be a compromise between the accuracy of analytical methods and the need to preserve the samples for further taxonomic studies. The conversion of the body area recorded by an optical counter or a camera, by converting the digitized area of an organism into individual biomass, was suggested as a suitable method to estimate total biomass. In this study, crustacean mesozooplankton from subtropical waters were analyzed, and individual dry weight and body area were compared. The obtained relationships agreed with other measurements of biomass obtained from a previous study in Antarctic waters. Gelatinous mesozooplankton from subtropical and Antarctic waters were also sampled and processed for body area and biomass. As expected, differences between crustacean and gelatinous plankton were highly significant. Transparent gelatinous organisms have a lower dry weight per unit area. Therefore, to estimate biomass from digitized images, pattern recognition discerning, at least, between crustaceans and gelatinous forms is required.

Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?

[EN] This study was performed to test the hypothesis that administration of recombinant human erythropoietin (rHuEpo) in humans increases maximal oxygen consumption by augmenting the maximal oxygen carrying capacity of blood. Systemic and leg oxygen delivery and oxygen uptake were studied during exercise in eight subjects before and after 13 wk of rHuEpo treatment and after isovolemic hemodilution to the same hemoglobin concentration observed before the start of rHuEpo administration. At peak exercise, leg oxygen delivery was increased from 1,777.0+/-102.0 ml/min before rHuEpo treatment to 2,079.8+/-120.7 ml/min after treatment. After hemodilution, oxygen delivery was decreased to the pretreatment value (1,710.3+/-138.1 ml/min). Fractional leg arterial oxygen extraction was unaffected at maximal exercise; hence, maximal leg oxygen uptake increased from 1,511.0+/-130.1 ml/min before treatment to 1,793.0+/-148.7 ml/min with rHuEpo and decreased after hemodilution to 1,428.0+/-111.6 ml/min. Pulmonary oxygen uptake at peak exercise increased from 3,950.0+/-160.7 before administration to 4,254.5+/-178.4 ml/min with rHuEpo and decreased to 4,059.0+/-161.1 ml/min with hemodilution (P=0.22, compared with values before rHuEpo treatment). Blood buffer capacity remained unaffected by rHuEpo treatment and hemodilution. The augmented hematocrit did not compromise peak cardiac output. In summary, in healthy humans, rHuEpo increases maximal oxygen consumption due to augmented systemic and muscular peak oxygen delivery.

Dynamically reconfigurable architectures for video coding and hyperspectral imaging systems

Programa de Doctorado: Ingeniería de Telecomunicación Avanzada.